Overall, YTHDF3 targeted PD-L1 to promote NSCLC immune evasion partially through escaping effector cell cytotoxicity CD8+ T mediated killing and antitumor immunity. The gene discussed is YTHDF3; the disease is non-small cell lung carcinoma.